Position in ALKS
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$33,315,626
-$8,016,821 QoQ
Shares Held
942,184
-36.2% QoQ
Ownership
0.565%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 95.59098859670723.ToString("F0")%
Shared 0.ToString("F0")%
None 4.409011403292775.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $649,006,825 across 25 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,924,600 | $227,506,966 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
309,220 | $183,361,275 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
602,643 | $79,392,188 | |
| 4 | VTRS |
Viatris Inc
|
2,645,328 | $35,738,381 | |
| 5 | ALKS |
Alkermes plc.
This page
|
942,184 | $33,315,626 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
623,288 | $30,011,317 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
450,764 | $23,299,991 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
580,428 | $17,482,491 |
All Filings in ALKS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,315,626 | 942,184 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $41,332,447 | 1,477,214 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $26,791,380 | 893,046 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $7,700,953 | 269,170 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,581,819 | 411,321 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $23,582,653 | 819,981 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $25,267,104 | 902,719 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,727,997 | 1,026,058 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $73,877,576 | 2,729,131 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $147,149,964 | 5,304,613 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $153,607,624 | 5,484,028 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||